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Helminth pathogens express papain-like 8 
cysteine peptidases, termed cathepsins, which 9 
have important roles in virulence, including 10 
host entry, tissue migration and the 11 
suppression of host immune responses. The 12 
liver fluke Fasciola hepatica, an emerging 13 
human pathogen, expresses the largest 14 
cathepsin L cysteine protease family yet 15 
described. Recent phylogenetic, biochemical 16 
and structural studies indicate that this family 17 
contains five separate clades, which exhibit 18 
overlapping but distinct substrate specificities 19 
created by a process of gene duplication 20 
followed by subtle residue divergence within 21 
the protease active site. The developmentally 22 
regulated expression of these proteases 23 
correlates with the passage of the parasite 24 
through host tissues and its encounters with 25 
different host macromolecules. 26 
Papain-like cysteine proteases 27 
Papain-like lysosomal cysteine proteases of 28 
the clan CA are expressed by all organisms 29 
from bacteria to mammals [1]. Humans 30 
express 11 different functional papain-like 31 
cysteine proteases (cathepsins L, S, K, F, W, 32 
V, O, B, C, H and X) that share a high degree 33 
of homology and substrate specificity because 34 
they arose from a common ancestor [2]. 35 
Some, including cathepsins B, L and S, are 36 
ubiquitously expressed in tissues and 37 
perform general household functions in 38 
protein turnover, although in immune cells 39 
they participate in antigen or major 40 
histocompatibility complex (MHC) II 41 
invariant chain processing [3]. Others display 42 
more restricted expression patterns and 43 
perform more specialized functions; for 44 
example, in osteoblasts, cathepsin K 45 
participates in bone re-modelling [4]. The 46 
papain-like cysteine proteases are of 47 
particular importance in medicine because 48 
their uncontrolled activities have been 49 
associated with diverse pathological disease 50 
states in humans including cancer 51 
metastasis, Alzheimer’s disease, muscular 52 
dystrophy, osteoporosis, rheumatoid arthritis 53 
and osteoarthritis [5]. Therefore, several 54 
research programs aim to develop selective 55 
inhibitors of these proteases; some, such as 56 
cathepsin K inhibitors for osteoporosis 57 
treatment, have reached clinical testing [6]. 58 
Papain-like cysteine proteases are also 59 
used by helminth, or worm, parasites in 60 
many aspects of their relationship with their 61 
animal and/or human hosts; for example, 62 
cathepsins facilitate skin and intestine 63 
infection, tissue migration, feeding and 64 
suppression of host immune effector cell 65 
functions [7]. Helminths are complex multi-66 
cellular organisms that include parasitic 67 
roundworms (nematodes) and flatworms 68 
(trematodes and cestodes). Human diseases 69 
caused by helminth parasites are among the 70 
most prevalent on earth, with >1 billion 71 
people infected worldwide, predominantly in 72 
poverty-stricken regions in developing 73 
countries. Despite the enormous amount of 74 
disease they cause and the burden they place 75 
on the global economy, the armoury of 76 
chemotherapeutic drugs available to combat 77 
these parasites is limited, consisting 78 
predominantly of praziquantel, ivermectin, 79 
albendazole and oxamniquine (for a review, 80 
see Ref. [8]). As with many other forms of 81 
pathogens, drug-resistant helminths have 82 
emerged and, therefore, there is an urgent 83 
need to identify additional strategies and 84 
target molecules for the development of new 85 
anti-parasitic drugs. 86 
Owing to the roles of papain-like cysteine 87 
proteases in fundamental aspects of the 88 
parasitic way of life, cathepsins are lead 89 
targets for the development of new 90 
chemotherapeutic interventions. Recent 91 
studies justify this approach; cysteine 92 
protease inhibitors impair the growth and 93 
fecundity of the liver fluke Fasciola hepatica 94 
in infected sheep [9] and the vinyl sulfone 95 
cysteine protease inhibitor K11777 causes 96 
considerable reductions of worm burden and 97 
parasite egg output in mice infected with the 98 
blood fluke Schistosoma mansoni [10]. 99 
K11777 also exhibits potent activity against 100 
some non-helminth parasites including 1 
Trypanosoma cruzi (the causative agent of 2 
Chagas’ disease) [11] and Entamoeba 3 
histolytica [12], thereby indicating that it 4 
might be possible to develop broad-spectrum 5 
anti-parasitics that could be employed in the 6 
treatment of individuals co-infected with 7 
pathogenic helminths and protozoans. 8 
However, whereas the development of anti-9 
parasitic drugs that target cysteine proteases 10 
might seem tangible, the fact that a large 11 
number of homologous proteases with 12 
overlapping specificity, as mentioned earlier, 13 
also have crucial functions in human tissues 14 
and are associated with various disease 15 
conditions presents a major challenge in 16 
identifying and developing parasite-specific 17 
inhibitors. Accordingly, it is imperative that 18 
we learn more about the biochemistry, 19 
structure and function of the parasitic 20 
proteases to enable comparisons to the 21 
human enzymes; these comparisons should 22 
facilitate the discovery of compounds that 23 
selectively inhibit the parasite enzymes. 24 
Much of our biochemical knowledge of the 25 
papain-like cathepsin cysteine proteases of 26 
helminth parasites comes from studies of 27 
trematodes, or flukes, of medical and 28 
veterinary significance. These include the 29 
blood flukes of the genus Schistosoma that 30 
cause bilharzia, or schistosomiasis, a disease 31 
afflicting >200 million people in >70 tropical 32 
countries and resulting in >280 000 deaths 33 
annually in sub-Saharan Africa alone [13]. 34 
Also included are several fish-borne 35 
infections caused by liver flukes of the 36 
genuses Clonorchis, Paragonimus and 37 
Opisthorchis, which put >600 million people 38 
at risk of infection across Asia [14,15], and 39 
liver flukes of the genus Fasciola that cause 40 
fasciolosis in animals such as sheep, cattle 41 
and water buffalo. Although fasciolosis was 42 
traditionally regarded as a world-wide 43 
disease of livestock, the disease has recently 44 
emerged as an important human zoonosis in 45 
South America, Egypt, Iran and Vietnam. 46 
Estimates indicate that 2.4–17.0 million 47 
people are infected worldwide, with a further 48 
91.1 million people currently living at risk of 49 
infection [14,16,17]. 50 
Here, we discuss how the biochemical and 51 
structural properties of papain-like cathepsin 52 
cysteine proteases of helminth parasites have 53 
evolved and adapted to perform their 54 
particular function in host–parasite 55 
interaction. We focus primarily on the 56 
cathepsin L proteases of F. hepatica because 57 
we have a better understanding of their 58 
phylogeny, biochemistry and function. We 59 
describe how subtle changes that occurred in 60 
the residues constituting the active site of the 61 
enzymes resulted in dramatic functional 62 
adaptations that enable the proteases to deal 63 
with the host macromolecules they encounter 64 
during migration and development of the 65 
parasite. 66 
Trematode (fluke) cysteine proteases 67 
Phylogenetic studies indicate that, at the 68 
time of helminth worm emergence, 480–540 69 
million years ago (MYA) [18] several 70 
cathepsin classes had evolved: (i) two with 71 
endopeptidase activity (cathepsin L and F); 72 
(ii) one with both exo- and endopeptidase 73 
activity (cathepsin B); and (iii) one with 74 
dipeptidylpeptidase activity (cathepsin C) 75 
[19–21] (Figure 1). This comparatively small 76 
array of papain-like cysteine proteases had a 77 
major role in the evolution and success of 78 
parasitism. Indeed, further expansion of 79 
these protease classes into families took place 80 
within individual parasitic lineages, thus, 81 
reflecting an adaptation to a new way of life 82 
in which nutrients were readily available but, 83 
at the same time, in which more energy was 84 
required to protect against host responses 85 
and to produce large numbers of offspring 86 
[20]. Interestingly, however, a clear 87 
divergence in the type of cathepsins 88 
expressed by different trematode species is 89 
observed: Fasciola spp. and Schistosoma spp. 90 
predominantly express cathepsin L-like 91 
proteases [22,23], whereas cathepsin F-like 92 
proteases are the major proteases expressed 93 
by Clonorchis spp., Paragonimus spp. and 94 
Opisthorchis spp. [24,25]. The reason(s) for 95 
this difference is unclear at present but, 96 
unlike Fasciola spp. and Schistosoma spp., 97 
the species of the other three parasitic 98 
genuses use fish as a second intermediate 99 
host, which could expose these pathogens to 100 
unique selective pressures that resulted in 101 
the evolution of cathepsin F-like protease 102 
families rather than cathepsin L-like 103 
enzymes. 104 
Cysteine proteases make up a large 105 
proportion of the total transcriptome of each 106 
of these trematode parasites, further 107 
emphasizing their importance in parasitism. 108 
For example, nearly 15% of the transcripts 109 
derived from adult F. hepatica [7] 110 
(http://www.sanger.ac.uk/Projects/Helminths/111 
), 10% from adult C. sinensis [26,27] and 18% 112 
and 27% from adult diploid and triploid 113 
Paragonimus westermani, respectively [28], 114 
encode cysteine proteases. 115 
Immunocytochemical studies show that 116 
helminth cysteine proteases are 117 
predominantly associated with the cells 118 
lining the gut lumen (gastrodermis), the 119 
reproductive structures (vitellaria) and the 120 
surface layers (tegument) of parasites, sites 1 
at which rapid protein degradation and 2 
synthesis takes place [29]. Cathepsin L, F 3 
and B proteases are also commonly found 4 
among the profile of molecules secreted by 5 
helminths, termed their secretome, which 6 
enables them to perform their functions in 7 
parasite–host interactions, for example, 8 
facilitating tissue penetration and disarming 9 
the soluble and cellular arms of the host 10 
immune system [23,30]. Cathepsin C, by 11 
contrast, functions in the hydrolysis of 12 
peptide products of host tissues and 13 
macromolecules that are degraded in the gut 14 
lumen and absorbed into the gastrodermis 15 
[7,31]. Further hydrolysis by 16 
aminopeptidases within the same cells leads 17 
to the release of free amino acids that are 18 
then distributed throughout the tissues of the 19 
parasite and used for growth and 20 
development [7]. 21 
Fasciola hepatica papain-like cysteine proteases 22 
F. hepatica expresses and secretes cathepsin 23 
L and B proteases, but not cathepsin F. 24 
Cysteine protease production is highly 25 
regulated during the development of the 26 
parasite in its hosts and correlates with its 27 
migration and maturation. Dormant larvae 28 
emerge from cysts in the duodenum and 29 
infect their mammalian hosts by penetrating 30 
the intestinal wall (Figure 2). Recently, 31 
McGonigle et al. [32] showed that RNA 32 
interference-mediated knock-down of either 33 
cathepsin B or cathepsin L transcripts in 34 
these infective juveniles blocked their ability 35 
to penetrate the host intestinal wall, thus, 36 
demonstrating that both enzyme types are 37 
required for host entry. Studies on the 38 
infective larvae of other trematodes, 39 
including those of Schistosoma spp., 40 
Trichobilharzia spp., Paragonimus spp. and 41 
Clonorchis spp., point to a universal use of 42 
cysteine proteases in host infection 43 
[19,33,34]. 44 
As the F. hepatica parasites enter the liver 45 
parenchyma and begin feeding on the tissue, 46 
cathepsin B expression diminishes and 47 
expression of cathepsin L proteases is 48 
upregulated. Biochemical and immunological 49 
studies indicate that, by the time the 50 
parasites have moved into the 51 
immunologically safe environment of the bile 52 
ducts, they become reliant solely on cathepsin 53 
L proteases [23]. Within the bile ducts, the 54 
parasite is an obligate blood-feeder and, 55 
hence, its nutrients are acquired 56 
predominantly from host haemoglobin and 57 
serum proteins. 58 
F. hepatica cathepsins are synthesized 59 
within the gastrodermal epithelial cells of the 60 
parasite and are stored in specialized 61 
secretory vesicles as inactive zymogens [35]. 62 
Recently, a 1.4 Å atomic structure of the 63 
major F. hepatica cathepsin L1 (FhCL1) 64 
zymogen was determined [36]; it is almost 65 
identical in tertiary structure to human 66 
cathepsin L1, although their primary 67 
structures exhibit only 35% identity [37]. The 68 
mature domains of the enzymes are arranged 69 
in two lobes: the left-hand lobe is 70 
predominantly composed of α-helices, 71 
whereas the right-hand lobe contains several 72 
elements of β-sheet. The substrate-binding 73 
cleft, containing the catalytic machinery of 74 
the enzyme, runs between the two lobes 75 
(Figure 3). Similarly to their mammalian 76 
counterparts, the Fasciola spp. zymogens 77 
contain an N-terminal extension, or 78 
prosegment, that binds the substrate cleft 79 
and prevents uncontrolled proteolysis during 80 
trafficking and storage [35–37] (Figures 3,4). 81 
Removal of the prosegment occurs by specific 82 
autocatalytic processing events and is 83 
facilitated by a low pH environment. In 84 
mammalian cells, this environment is 85 
provided by the acidic lysosome but, in 86 
helminth parasites, activation occurs within 87 
the slightly acidic milieu of the parasite gut 88 
lumen [20,35]. In the case of F. hepatica 89 
cathepsin L, we have shown that auto-90 
activation from a pro-enzyme to a mature 91 
active enzyme occurs over a broad pH range 92 
(4.0–7.3), but is ~40-fold faster at pH 4.5 93 
than at pH 7.0 [38]. Thus, the acidic gut of 94 
the parasite provides a perfect environment 95 
to facilitate denaturing of ingested host 96 
macromolecules and activation of the 97 
digestive enzymes (not dissimilar to the 98 
mammalian gut). A remarkable feature of 99 
FhCL1 is its broad pH range for activity (pH 100 
3.0–9.0) coupled with high stability at 101 
neutral pH (up to 10 days at 37°C); by 102 
contrast, the human cathepsin L homologue 103 
is most active at pH 4.5 and inactivates 104 
within minutes at pH 7.0 [39]. These 105 
properties enable the parasite enzyme to 106 
function for long periods within the parasite 107 
gut (pH 5.5), in which 1.5 × 108 red blood cells 108 
are degraded hour−1 worm−1, and in the host 109 
tissue (pH 7.3), which is degraded to 110 
facilitate their migration. 111 
Phylogenetic studies reveal a large family of F. 112 
hepatica cathepsin L proteases 113 
The cathepsin L proteases have undergone a 114 
great expansion within the Fasciola spp. A 115 
phylogenetic analysis of F. hepatica genes 116 
deposited in public databases revealed that 117 
this parasite expresses the largest 118 
monophyletic cysteine protease family 119 
described to date [23,40]. The family can be 120 
grouped into five distinct phylogenetic clades; 1 
complementary DNAs (cDNAs) for two of 2 
these are found only in the early infective 3 
larvae (clades FhCL3 and FhCL4), whereas 4 
the remaining three clades (clades FhCL1, 5 
FhCL2 and FhCL5) were derived from adult 6 
parasites taken from bile ducts [23,40] 7 
(Figure 5). This cathepsin L family is 8 
estimated to have expanded within the genus 9 
Fasciola by a series of gene duplications 10 
followed by divergence beginning 135 MYA. 11 
Irving et al. [40] estimated that most of the 12 
expansion took place ~25 MYA, which was co-13 
incident with climatic conditions that 14 
favoured the development of grasslands and 15 
the expansion of common F. hepatica 16 
mammalian hosts (e.g. cattle and sheep). 17 
Accordingly, the divergence of the cathepsin 18 
L protease family seems to have been 19 
important in the evolution and adaptation of 20 
the parasite to a wider host range [23,40]. 21 
Proteomics studies of the cysteine 22 
proteases secreted by mature liver flukes in 23 
culture and in situ within the bile duct 24 
support the earlier phylogenetic analysis and 25 
highlight several important observations 26 
[23,41] (Figure 5). First, FhCL3 and FhCL4 27 
cathepsin L proteases were not detected in 28 
the adult stage secretory proteins, supporting 29 
a specific role for these proteases in the early-30 
stage juvenile flukes that initiate infection 31 
through the intestinal wall [32]. Second, 32 
adult parasites secreted protease members of 33 
all remaining clades (i.e. FhCL1, FhCL2 and 34 
FhCL5); however, the clade FhCL1 and 35 
FhCL2 proteases were, by far, the most 36 
predominantly expressed proteins 37 
(accounting for 67.39% and 27.63% of total 38 
secreted cathepsin Ls, respectively). This 39 
finding indicates that clades FhCL1 and 40 
FhCL2 are most crucial for parasite survival 41 
and adaptation. Third, proteases of a FhCL1 42 
sub-clade, FgCL1C, were not present in the 43 
F. hepatica secretome, consistent with our 44 
findings [23] that genes in this sub-clade are 45 
present in the related tropical liver fluke, 46 
Fasciola gigantica, but not in the F. hepatica 47 
nucleotide databases. It seems that the 48 
FgCL1C sub-clade expanded most recently 49 
and was important in F. hepatica and F. 50 
gigantica speciation ~17 MYA and their 51 
subsequent adaptation to their specific hosts 52 
[40]. 53 
Mature F. hepatica did not secrete any 54 
proteases other than cathepsin L cysteine 55 
proteases, confirming that adult parasites 56 
living in the bile duct rely only on these 57 
enzymes for feeding on host blood [23,41,42]. 58 
The parasite draws blood through punctures 59 
it makes in the duct wall and the nutrients 60 
obtained from this process are used to 61 
produce an enormous number of progeny (30–62 
50 000 eggs day−1worm−1) [7]. Accordingly, 63 
FhCL1, FhCL2 and FhCL5 cathepsin L 64 
proteases must collectively possess hydrolytic 65 
machinery capable of digesting the 66 
macromolecules in the bloodmeal to peptides 67 
that are sufficiently small to be absorbed into 68 
the parasite gastrodermis. Recently, we 69 
showed that one of these enzymes, FhCL1, 70 
can degrade haemoglobin to peptides of 71 
between 3–14 amino acids; these presumably 72 
are absorbed into the gastrodermis for 73 
further catabolism to amino acids by 74 
intracellular cathepsin C and 75 
aminopeptidases [7,21,38]. 76 
All cathepsin L proteases detected in the 77 
secretions of adult F. hepatica were fully 78 
processed to mature enzymes, indicating that 79 
the events that lead to prosegment removal is 80 
completed within the parasite gut lumen [23]. 81 
A comparison of the primary structures of the 82 
prosegments of the various phylogenetic 83 
clades shows that they are highly conserved, 84 
except within a 21 amino acid stretch before 85 
the junction between the prosegment and 86 
mature enzyme [23,37,43] (Figure 4). The 87 
FhCL1 atomic structure shows that the final 88 
12 residues in this prosegment C-terminal 89 
region do not make contacts with the main 90 
body of the enzyme but, rather, move freely 91 
in space, creating a ‘protease-accessible’ 92 
region that facilitates prosegment removal 93 
[43]. We have proposed that the cleavage 94 
events leading to prosegment removal take 95 
place in two steps [23]. Initially, in a 96 
bimolecular process, a small number of 97 
inactive cathepsin L zymogens are trans-98 
activated by another enzyme located in the 99 
gastrodermal cells, an asparaginyl 100 
endopeptidase [44], that cleaves peptide 101 
bonds involving Asn residues close to the 102 
junction of the prosegment and mature 103 
domain. Cathepsin Ls activated by this 104 
process are then free to remove prosegments 105 
from other cathepsin Ls through specific 106 
cleavage at the Leu-Ser↓His motif and, thus, 107 
the process increases exponentially [36]. 108 
Mutations that alter this motif to a Pro-109 
Ser↓His motif prevent cathepsin L activation 110 
[43]. This proposal for enzyme activation is 111 
supported by sequence alignments of the five 112 
F. hepatica cathepsin L clades (Figure 5); 113 
despite the lack of conservation at the 114 
prosegment C terminus, the cleavage site for 115 
asparaginyl endopeptidase and the 116 
autocatalytic cleavage Leu-Ser↓His motif are 117 
preserved in all phylogenetic clades. 118 
Fasciola cathepsins have varying but 119 
overlapping substrate specificities 120 
Gene duplication followed by divergence is 1 
one of the primary means by which 2 
organisms generate proteins with new 3 
functions [45]. The tight regulation of the 4 
expression of the various F. hepatica 5 
cathepsin L clades as the parasite develops 6 
implies that the specific biochemical activity 7 
of certain clades are required at different 8 
stages of development as the parasite moves 9 
to new environments and encounters 10 
different macromolecular substrates 11 
(Figure 2). Understanding the functional 12 
diversity of the various members of the gene 13 
family, therefore, is important for 14 
understanding pathogen virulence and 15 
adaptation. 16 
The active site of papain-like cysteine 17 
proteases is short; although it comprises four 18 
subsites (S2–S1–S1′–S2′) that interact with 19 
the corresponding P2–P1–P1′–P2′ residues of 20 
the protein substrate, the scissile bond being 21 
between P1–P1′ [1,46]. Substrate binding 22 
specificity is predominantly governed by the 23 
residues that form a deep S2 subsite pocket 24 
capable of holding the substrate P2 amino 25 
acid and positioning the scissile bond P1–P1′ 26 
into the S1 subsite for cleavage [1,46]. Within 27 
the 3D structures of FhCL1, human 28 
cathepsin L and cathepsin K, the S2 subsite 29 
is composed of residues occupying positions 30 
67, 68, 133, 157, 160 and 205, which exhibit 31 
variation among members of the papain 32 
superfamily. An analysis of these residues in 33 
the various Fasciola spp. cathepsin L clades 34 
reveals divergence within the S2 subsite, in 35 
particular at the three positions that have 36 
the greatest influence on P2 binding (i.e. at 37 
residues 67, 157 and 205) [36] (Figure 3). Our 38 
biochemical data using recombinant versions 39 
of FhCL1 and FhCL2 proteases show how 40 
important changes in these positions can be; 41 
for example, FhCL1 (Leu67, Val157 and 42 
Leu205) cleaves substrates with hydrophobic 43 
residues (Phe and Leu) in the P2 position 44 
with catalytic rates (kcat/Km) that are 25- and 45 
eightfold greater, respectively, than FhCL2 46 
(Tyr67, Leu157 and Leu205). Furthermore, 47 
in comparison to human cathepsin L (Leu67, 48 
Met157, Ala205), which can accommodate a 49 
wide range of amino acids in the S2 subsite, 50 
the S2 subsite of FhCL1 is restricted. Using 51 
mass spectrometry, we found that those 52 
residues in host haemoglobin that were most 53 
susceptible to cleavage by FhCL1 were 54 
invariably hydrophobic residues and in the 55 
order Leu>Val>Ala>Phe. Together, these four 56 
residues make up ~42% of the haemoglobin 57 
molecule and, therefore, it seems that FhCL1 58 
has been specifically adapted to degrade the 59 
host substrate, which it exploits as nutrient 60 
[38]. 61 
A comparison with the parasite and 62 
human cysteine protease homologues shows 63 
that the FhCL2 S2 subsite is identical to that 64 
of human cathepsin K (Figure 3). 65 
Biochemical studies indicate that, like 66 
cathepsin K, FhCL2 readily accommodates 67 
substrates with a bulky proline residue in the 68 
P2 position; by contrast, these substrates are 69 
poorly cleaved by FhCL1 and not at all by 70 
human cathepsin L [43]. Both cathepsin K 71 
and FhCL2 also possess the unique ability to 72 
cleave native collagen, which contains a 73 
repeat motif of Gly-Pro-Xaa (in which Xaa is 74 
any amino acid). Comparison of the atomic 75 
structures of the two enzymes show that this 76 
unique collagenase-like activity is, in part, 77 
due to the presence of Tyr67 (not found at 78 
this position in any other cathepsin 79 
proteases) at the entrance of the S2 pocket; 80 
this site can form stabilizing ring–ring 81 
interactions between the five-membered 82 
proline ring of the substrate [36]. This is an 83 
example of convergent evolution, whereby 84 
positive selection acting on the residues 85 
within the active site of two vastly distant 86 
enzymes has endowed them with similar 87 
biochemical and functional properties. In 88 
humans, cathepsin-K-mediated collagen 89 
cleavage is essential to its function in bone 90 
remodelling [47]; by contrast, in Fasciola 91 
spp., which must penetrate and migrate 92 
through large host organs including the liver, 93 
this FhCL2 activity is crucial for degrading 94 
collagen-rich interstitial matrices. 95 
Interestingly, adult clade FhCL5 that 96 
diverged from FhCL2 before its divergence 97 
from FhCL1 (Figure 5) exhibits an 98 
intermediate S2 subsite (Leu67, Leu157 and 99 
Leu205). Like clade FhCL1, it does not 100 
readily accommodate substrates with a P2 101 
proline residue [48]. Thus, separation of the 102 
FhCL1 and FhCL5 clades from the FhCL2 103 
clade was accompanied by the loss of the 104 
ability to cleave substrates, like collagen, 105 
with a P2 proline. At the same time, this 106 
alteration enabled the S2 pocket of FhCL1 to 107 
open up so that it could accommodate 108 
hydrophobic residues that were most common 109 
in host haemoglobin. No biochemical data are 110 
available for the infective larval proteases of 111 
clades FhCL3 and FhCL4 but, because these 112 
are considered the most ancient of the clades 113 
from which the FhCL2 and FhCL5–FhCL1 114 
lineages diverged, it is likely that they 115 
possess hybrid-like specificities [40]. 116 
Concluding remarks 117 
Helminth parasites have exploited papain-118 
like cysteine proteases to perform a wide 119 
range of functions that enable them to reside 1 
in their mammalian hosts. Despite the 2 
evolutionary distance between helminth 3 
parasites and humans, their papain-like 4 
cysteine proteases share many biochemical 5 
and structural similarities. Given that 6 
substrate specificity in these proteases is 7 
largely governed by a few interactions 8 
between the substrate P2 amino acid and 9 
residues within the S2 subsite of the enzyme, 10 
it is not surprising that the differences 11 
observed between the parasite and human 12 
enzymes are minor. Turk and Guncar [1] 13 
suggest that it might be difficult to design 14 
inhibitors that can distinguish between the 15 
human enzymes because they differ only 16 
subtly in their substrate specificity. Finding 17 
inhibitors that potently inactivate parasite 18 
papain-like cysteine proteases without 19 
affecting one or more host enzymes will pose 20 
an even greater challenge. However, drug 21 
design efforts could exploit bioavailability 22 
and pharmo-kinetic and -dynamic properties 23 
to enhance the probability of inhibitors 24 
preferentially reaching their parasite target. 25 
Availability of recombinant functional 26 
parasite proteases will be invaluable in the 27 
search for selective lead-like compounds with 28 
these characteristics within synthetic or 29 
natural chemical libraries. Additionally, or 30 
alternatively, we could take advantage of the 31 
exquisite selectivity by which the host 32 
immune system can distinguish foreign 33 
molecules and epitopes to target the papain-34 
like cathepsin cysteine proteases of helminth 35 
parasites as vaccine molecules. Such an 36 
approach has been successfully taken in the 37 
path towards the development of a first-38 
generation recombinant FhCL1 vaccine that 39 
protects domestic animals against infection 40 
with the liver fluke F. hepatica [49]. 41 
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Infection Trematode Abbrev. Definitive hosts Intermediate hosts  Distribution




Herbivores: sheep, cattle, humans Freshwater snails World-wide 
Africa, Asia 




Sheep, cattle, horses, humans Freshwater snails Asia-Pacific 
South America, Africa 
Clonorchiasis Clonorchis sinensis Cs Dogs, pigs, cats, camels, humans Freshwater snails, carp Asia-Pacific 
Opisthorchiasis Opisthorchis viverrini Ov Dogs, cats, pigs, humans Freshwater snails, fish Eastern Europe, Asia-Pacific 























Ti BS  1 
Figure 1. Papain-like cysteine proteases of trematode pathogens. Human diseases caused by trematode (flatworm) parasites are among the 2 
most prevalent on earth and predominantly occur in developing countries. Trematode pathogens express four major classes of cathepsin 3 
proteases (L, B, F and C) that have functions in parasite virulence including tissue invasion and feeding. (a) The major trematode pathogens of 4 
humans and animals. (b) Bootstrapped (1000 trials) neighbour-joining phylogenetic tree showing the evolutionary relationship of the trematode 5 
cathepsin superfamily. The tree was constructed using trematode cDNA sequences (including the prosegment region). The branches are 6 
coloured according to the four major enzyme classes. Abbreviations: CB, cathepsin B; CC, cathepsin C; CL, cathepsin L; CP, cysteine protease; 7 
Cs, Clonorchis sinensis; Fg, Fasciola gigantica; Fh, Fasciola hepatica; Ov, Opisthorchis viverrini; Pw, Paragonimus westermani; Sj, Schistosoma 8 










(a) Infective larvae (b) Immature stage (c) Mature stage
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Figure 2. Developmental regulation of F. hepatica cathepsin proteases. Trematode pathogens such as F. hepatica undergo complex life-cycles 2 
involving transitions between host organ systems and tissues. Movement from one site to another, as the life-cycle progresses, is associated 3 
with the differential expression of cathepsin enzymes. (a) Penetration of the host intestinal wall by newly excysted juvenile (NEJ) F. hepatica is 4 
facilitated by the secretion of proteolytic enzymes. This process involves cathepsin B and clade 3 cathepsin Ls. (b) The migration of immature 5 
flukes through host liver tissue corresponds to a period of rapid growth and development of the parasite. At this stage, host protein degradation 6 
is achieved primarily by Fasciola clade 1 and 2 cathepsin Ls, although some cathepsin B and clade 3 and 4 cathepsin L activity could remain. (c) 7 
Adult F. hepatica resides within the bile ducts where it feeds on host red blood cells. Proteomics analyses have shown that clade 1, 2 and 5 8 
cathepsin Ls are the only proteases secreted by adult flukes, thus, indicating crucial roles for these enzymes in penetrating the bile duct wall and 9 











67             68             133            157            158           160            205 
Human cathepsin L Leu Met Ala Met Asp Gly Ala
Human cathepsin K Tyr Met Ala Leu Asn Ala Leu
Adult:      FhCL 1A Leu Met Ala Val Asn Ala Leu
                FhCL 1B Leu Met Ala Leu Asn Ala Leu
                FhCL 2 Tyr Met Ala Leu Thr Ala Leu
                FhCL 5 Leu Met Ala Leu Asn Gly Leu
Juvenile: FhCL 3 Trp Met Ala Val Thr Ala Val
                FhCL 4 Phe Met Ala Leu Asn Ala Phe
Ti BS  11 
Figure 3. A structural analysis of F. hepatica cathepsin L proteases. Fasciola spp. cathepsin Ls are stored in specialized secretory vesicles 1 
within the gut epithelial cells of the parasite as inactive zymogens, which consist of a prosegment and mature enzyme domain. The prosegment 2 
is removed by catalytic cleavage after secretion into the parasite intestine to reveal an active mature protease. (a) Surface representation of the 3 
major F. hepatica secreted cathepsin L protease (FhCL1) (Protein Data Bank [PDB] ID: 2O6X). The prosegment is shown as a green ribbon and 4 
the catalytic machinery is shown in yellow (P1 residues) and magenta (P2 residues). (b) At low pH (4.0–4.5), the prosegment is auto-catalytically 5 
removed to produce the mature active enzyme. (c) Detail from the active site of the enzyme. S2 residues that determine substrate-binding 6 
specificity are labelled. Figures were created using Pymol (http://www.pymol.org). (d) Comparison of the residues from the S2 active site that 7 
contribute to differential substrate-binding in F. hepatica cathepsin Ls (clades FhCL1–FhCL5) and human cathepsins L and K. The S2 residues 8 
that confer substrate specificity are in red. Residues were identified using primary sequence alignments and analyses of the FhCL1 atomic 9 
structure (PDB ID: 2O6X) [36]. 10 
(b) FhCL consensus -E----S--LSHG--Y------
FhCL 1A_ie1      T.MSRA.DI..H.VP.EANNRa
FhCL 1A_pe       T.MSRA.DI..H.VP.EANNRa
FhCL 1A_au3      T.MSRA.DI..H.VP.EANNRa
FhCL 1A_pl       T.MSRA.DI..H.VP.ETNNRa
FhCL 1A_pt1      T.MSRA.DI..H.VP.ETNNRa
FhCL 1A_tr       T.MPRA.DI..H.IP.EANNRa
CL1A consensus   T.MSRA.DI..H.VP.EANNRa
FhCL 1B_n11      T.MPRA.DI..H.IP.EANNRa
FhCL 1B_ar       T.MPRA.DI..H.IP.EANNRa
CL1B consensus   T.MPRA.DI..H.IP.EANNRa
FhCL 2_jn3       I.MPRS.EL..H.IP.KAKNRa
FhCL 2_ie2       I.IPRS.EL..R.IP.KANKLa
FhCL 2_chC       I.IPRS.EL..R.IP.KANKLa
FgCL 2_thD       I.IPRS.EL..R.IP.KANKPa
CL2 consensus    I.IPRS.EL..R.IP.KANKLa
FhCL 5_au4       T.MPRA.EL..H.IP.KANKRa
FgCL 5_thC       T.MPHR.DI..H.IP.EANKRa
FhCL 5_au5       T.MPRA.EL..H.IP.KANKRa
CL5 consensus    T.MPRA.EL..H.IP.KANKRa
FhCL 3_nl64      M.MSPV.ES..D.IS.EAEGKd
FgCL 3_thG       I.MSPE.ES..D.IS.EAEGNd
FhCL 3_nl22      M.MSPV.ES..D.VS.EAEGNd
FhCL 3_uy3       M.MSPE.ES..D.IS.EAEGNd
CL3 consensus    M.MSP-.ES..D.IS.EAEGNd
FhCL 4_uy4       R.IPRA.DM..H.IP.EANDRa
FgCL 4_thH       R.IPRA.DIH.H.IP.EANDRa
CL4 consensus    R.IPRA.D--.H.IP.EANDRa
(a)
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Figure 4. A structural and sequence analysis of Fasciola cathepsin L prosegments. Cathepsin L prosegments regulate enzyme activity by 12 
binding to the substrate cleft and act as molecular chaperones to ensure correct folding of the enzyme. Prosegment removal is mediated by 13 
cleavage at two conserved motifs towards the C-terminal end of the molecule. (a) The atomic structure of the F. hepatica major secreted 14 
cathepsin L protease prosegment region (PDB ID: 2O6X). The conserved Leu-Ser↓His motif required for zymogen auto-catalytic processing is 15 
shown in red and the asparagine residues required for trans-activation by apsaraginyl endopeptidases are shown in blue. The region containing 16 
the Leu-Ser↓His motif and asparagine residues in the atomic structure of the molecule is disordered; however, they have been drawn for 17 
illustrative purposes only. The figure was created using Pymol (http://www.pymol.org). (b) Primary sequence alignment of the non-conserved 18 
Fasciola cathepsin L protease prosegment C-terminal regions. A consensus sequence for all Fasciola cathepsin Ls (FhCL consensus) is shown 19 
at the top of the alignment as are consensus sequences for individual clades (e.g. CL1A consensus, CL1B consensus, etc.). Gaps in the 20 
alignment are represented by a dash (−) and amino acids that are conserved in all sequences are indicated by a dot (⋅). Prosegment residues 21 
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Figure 5. A phylogenetic analysis of the Fasciola cathepsin L gene family. The Fasciola cathepsin L gene family expanded by a series of gene 4 
duplications, followed by divergence of residues in the active site, which gave rise to three clades associated with mature adult worms and two 5 
clades specific to infective juvenile stages. These changes resulted in a repertoire of cathepsin L proteases with overlapping and complementary 6 
substrate specificities. Bootstrapped (1000 trials) neighbour-joining tree constructed using F. hepatica and F. gigantica cathepsin L cDNA 7 
sequences. The tree is rooted to Carica papaya papain. The cathepsin L proteases expressed and secreted by adult flukes are coloured and the 8 
brackets and figures represent their expression levels. Figure adapted from Ref. [23]. 9 
